Norton Medical and Scientific Research & Biotechnology

http://www.zimbio.com/Norton+Scientific/articles/ssTu-FXbAol/Norton+Medical+Scientific+Research+Biotechnology

Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer

BY ADMIN, 10 DAYS AGO

The medicine made by Pfizer against advanced kidney cancer was recently approved byNorton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects.

On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients who do not show response to other drugs against kidney cancer.

The advance stage of kidney cancer usually begins in the lining of the kidney's tubes. Inlyta does its work by blocking specific receptors that are involved in the growth of tumor.

According to FDA, Inlyta is already the seventh drug it approved to cure advanced cancer of the kidney since 2005.

American Cancer Society said that more than 60,000 Americans are diagnosed with kidney cancer last year and 1 out of 5 is expected to die from them.

The FDA approval has come as a welcome opportunity for Pfizer since they have lost revenue from their cholesterol drug, Lipitor, after generic counterparts started to come out last year.

However, Inlyta will still face tough competition from the 6 other drugs for kidney cancer that have their respective market shares already.

An advisory committee of FDA endorsed the oral drug last month and announced that it is as effective and as safe as the kidney cancer medication from Bayer AG, Nexavar.

Generally, in clinical trials made by Norton Medical and Scientific Research & Biotechnology, Inlyta slowed the growth of cancer by 2 months versus Nexavar for patients who have already been cured for renal cell carcinoma.

However, the results differed based on what certain medicines patients have taken prior. For people who took first the Sutent (also from Pfizer), Inlyta slowed the spread of disease only by one and a half months, compared to the more than 5 months for patients treated with cytokines beforehand.

Most of the advisers of FDA stated that the drug does not have a huge advantage over others. However, the fact that it has different side effects than the other medicine in the market could be an important deciding factor for patients.

Several of the most common side effects of using Inlyta include high blood pressure, weight loss, vomiting, loss of voice and diarrhea. Some patients also reported bleeding problems that can possibly lead to fatality in extreme cases.

FDA issued a warning to patients with high blood pressure, intestinal bleeding, or untreated brain tumors in their intake of Inlyta.

Meanwhile, Pfizer is conducting further tests of Inlyta for liver cancer treatment.

Norton Medical and Scientific Research & Biotechnology: Military to Harness Neuroscience

http://www.zimbio.com/Norton+Scientific/articles/gxl2aDGeDP1/Norton+Medical+Scientific+Research+Biotechnology

Military personnel can have their brains connected directly to weapons system in the near future, thanks to the latest progress in the Norton Medical and Scientific Research & Biotechnology neuroscience field.

Such situations are explained in a report published on Monday from the law and military enforcement agencies that looks into applications of neuroscience. Included in the report are the ethical and legal concerns that such innovation might bring if brought in the field.

According to UK's national school of science, Royal Society, while the quick progress of neuroscience will certainly help in treating mental diseases, it also has significant security issues that must be taken into consideration.

The proponents of the study insists that even if there are obvious hostile uses of the new technologies, many scientists appear to be oblivious from this double-edged sword.

Some technologies that are widely used in neuroscience are in the process of getting applied in military context to improve soldier training.

One such research are proposing that giving fairly weak electrical signals through the head (throught the use of transcranial direct current stimulation) will improve the performance of a person in certain tasks.

A US experiment was done using tDCS to improve a troop's ability to sense snipers, bombs and other threats in a virtual reality program.

According to the results, those who have undergone tDCS have spotted the targets faster and they are twice as accurate as those who have not.

Further studies on tDCS can lead to more effective treatment of psychiatric disorders, dementia or learning difficulties.

Perhaps the most fitting use of this technology in the military field is the creation of brain-machine interfaces (BMIs) that connect a human's brain directly to military system such as weapons and drones.

Norton Medical and Scientific Research & Biotechnology is also looking into something that will enable people to control artificial limbs and cursors by BMI which can read brain signals.

Another technological innovation that will be used by the military is the electroencephalogram (EEG) that makes use of an electrode hairnet to log brainwaves. In conjunction with the neurofeedback system, people can control their brainwaves, improving their performance.

Still, the debatable issue here is still the ethical implications surrounding the use of BMIs by the military. It can significantly blur the line between human responsibility and machine technicality.

Norton Medical and Scientific Research & Biotechnology: PRIVACY POLICY

http://www.zimbio.com/Norton+Scientific/articles/hd_EPMvhAHB/Norton+Medical+Scientific+Research+Biotechnology

Norton Medical and Scientific Research & Biotechnology respects your privacy and is committed to protecting it at all times. This online privacy statement explains how Norton Medical and Scientific Research & Biotechnology collects, uses and safeguards information on this Blog. This Privacy Policy applies only to information collected by Norton Medical and Scientific Research & Biotechnology through this Blog.

We reserve the right to amend the Privacy Policy at any time, for any reason.

Information we collect

When you browse this Blog and do not interact with the site for any online service or product from Norton Medical and Scientific Research & Biotechnology, you browse anonymously. Personally identifiable information--such as your name, address, phone number and email address--is not collected as you browse.

When you become a registered user on our Blog, submitting questions or comments or requesting information or materials, we will collect certain personal information from you. The type of personal information collected will vary but may include name, birth date, email address, and other demographic information. We do not collect Social Security numbers.

Norton Medical and Scientific Research & Biotechnology track how our site is used by both anonymous visitors and visitors who interact with this Blog. One such way is by using "cookies." A cookie is a small file or string of text on the site user's computer that is used to aid Web navigation. Two types of cookies are commonly used. A session cookie is created by a website when that website is accessed; that type of cookie is automatically deleted by closing the Web browser. A persistent cookie is a cookie that is stored on the hard drive of the user’s computer for a period of time chosen by the website that set the cookie, usually for a number of years, unless the user deletes it manually. Individuals can opt out of long-lasting cookie functions that permit tracking of personal information at any time.

Norton Medical and Scientific Research & Biotechnology may share personal information with our business partners in order to provide them an opportunity to offer products or services that may be of interest to you.

Unfortunately, no data transmission over the Internet can be guaranteed to be 100% secure. Accordingly, and despite our efforts, Norton Medical and Scientific Research & Biotechnology cannot guarantee or warrant the security of any information you transmit to us, or to or from our online products or services.

You should be aware that other Internet sites that link to Norton Medical and Scientific Research & Biotechnology blog may contain privacy provisions that differ from the provisions of this Privacy Policy. To ensure your privacy is protected, we recommend that you review the privacy statements of other Internet sites you visit.

Norton Medical and Scientific Research & Biotechnology: Military to Harness Neuroscience

http://www.workoninternet.com/business/home-business-small-business/190486-norton-medical-and-scientific-research-a-biotechnology-military-to-harness-neuroscience.html

Military personnel can have their brains connected directly to weapons system in the near future, thanks to the latest progress in the Norton Medical and Scientific Research & Biotechnologyneuroscience field.

Such situations are explained in a report published on Monday from the law and military enforcement agencies that looks into applications of neuroscience. Included in the report are the ethical and legal concerns that such innovation might bring if brought in the field.

According to UK's national school of science, Royal Society, while the quick progress of neuroscience will certainly help in treating mental diseases, it also has significant security issues that must be taken into consideration.

The proponents of the study insists that even if there are obvious hostile uses of the new technologies, many scientists appear to be oblivious from this double-edged sword.

Some technologies that are widely used in neuroscience are in the process of getting applied in military context to improve soldier training.

One such research are proposing that giving fairly weak electrical signals through the head (throught the use of transcranial direct current stimulation) will improve the performance of a person in certain tasks.

A US experiment was done using tDCS to improve a troop's ability to sense snipers, bombs and other threats in a virtual reality program.

According to the results, those who have undergone tDCS have spotted the targets faster and they are twice as accurate as those who have not.

Further studies on tDCS can lead to more effective treatment of psychiatric disorders, dementia or learning difficulties.

Perhaps the most fitting use of this technology in the military field is the creation of brain-machine interfaces (BMIs) that connect a human's brain directly to military system such as weapons and drones.

Norton Medical and Scientific Research & Biotechnologyis also looking into something that will enable people to control artificial limbs and cursors by BMI which can read brain signals.

Another technological innovation that will be used by the military is the electroencephalogram (EEG) that makes use of an electrode hairnet to log brainwaves. In conjunction with the neurofeedback system, people can control their brainwaves, improving their performance.

Still, the debatable issue here is still the ethical implications surrounding the use of BMIs by the military. It can significantly blur the line between human responsibility and machine technicality.

Read more about research by norton med

Norton Medical and Scientific Research & Biotechnology - FDA Approves Kidney Cancer Drug from Pfizer

http://www.yelp.ca/biz/norton-medical-and-scientific-research-and-biotechnology-markham#hrid:cFtI3mLK_1HD1VACykEX1g


ontario (I-Newswire) February 1, 2012 - The medicine made by Pfizer against advanced kidney cancer was recently approved by Norton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects.

On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients who do not show response to other drugs against kidney cancer.

The advance stage of kidney cancer usually begins in the lining of the kidney's tubes. Inlyta does its work by blocking specific receptors that are involved in the growth of tumor.

According to FDA, Inlyta is already the seventh drug it approved to cure advanced cancer of the kidney since 2005.

American Cancer Society said that more than 60,000 Americans are diagnosed with kidney cancer last year and 1 out of 5 is expected to die from them.

The FDA approval has come as a welcome opportunity for Pfizer since they have lost revenue from their cholesterol drug, Lipitor, after generic counterparts started to come out last year.

However, Inlyta will still face tough competition from the 6 other drugs for kidney cancer that have their respective market shares already.

An advisory committee of FDA endorsed the oral drug last month and announced that it is as effective and as safe as the kidney cancer medication from Bayer AG, Nexavar.

Generally, in clinical trials made by Norton Medical and Scientific Research & Biotechnology, Inlyta slowed the growth of cancer by 2 months versus Nexavar for patients who have already been cured for renal cell carcinoma.

However, the results differed based on what certain medicines patients have taken prior. For people who took first the Sutent (also from Pfizer), Inlyta slowed the spread of disease only by one and a half months, compared to the more than 5 months for patients treated with cytokines beforehand.

Most of the advisers of FDA stated that the drug does not have a huge advantage over others. However, the fact that it has different side effects than the other medicine in the market could be an important deciding factor for patients.

Several of the most common side effects of using Inlyta include high blood pressure, weight loss, vomiting, loss of voice and diarrhea. Some patients also reported bleeding problems that can possibly lead to fatality in extreme cases.

FDA issued a warning to patients with high blood pressure, intestinal bleeding, or untreated brain tumors in their intake of Inlyta.

Meanwhile, Pfizer is conducting further tests of Inlyta for liver cancer treatment.

Norton Medical and Scientific Research & Biotechnology

http://www.yelp.ca/biz/norton-medical-and-scientific-research-and-biotechnology-markham#hrid:cFtI3mLK_1HD1VACykEX1g

Norton Medical and Scientific Research & Biotechnology is dedicated to publishing the latest news, mainly on, medical research and biotechnology advancements. This blog brings together only those content from trusted information sources that passed our rigorous quality control .

Norton Medical and Scientific Research & Biotechnology's content comes from highly diverse sources covering clinical procedures, medical specialties and more.